-
公开(公告)号:US10968269B1
公开(公告)日:2021-04-06
申请号:US12919405
申请日:2008-12-30
申请人: Jørgen Schøller , Liselotte Brix , Henrik Pedersen
发明人: Jørgen Schøller , Liselotte Brix , Henrik Pedersen
摘要: Novel compounds carrying ligands capable of binding to counter receptors on relevant target cells are disclosed. The compounds possess a number of advantageous features, rendering them very suitable for a wide range of applications, including use as detection systems, detection of relevant target cells as well as a number of other methods. In particular, novel MHC complexes comprising one or more MHC molecules containing one or more Borrelia derived peptides are disclosed. The possibility of presenting to the target cells a plurality of MHC-peptide complexes makes the MHC complexes according to the present invention an extremely powerful tool e.g. in the field of therapy and diagnosis. The invention generally relates to the sample-mounted use of MHC complexes and MHC multimers.
Also comprised by the invention is the field of therapy and vaccine, including therapeutic/vaccine methods and therapeutic/vaccine compositions.-
公开(公告)号:US10722562B2
公开(公告)日:2020-07-28
申请号:US13055321
申请日:2009-07-22
申请人: Henrik Pedersen , Liselotte Brix
发明人: Henrik Pedersen , Liselotte Brix
摘要: A method for the repair of a unit, by specific diagnosis of the undesired state, and its appropriate repair, using said specific diagnosis as a means to repair in an appropriate way said unit. The diagnosis and repair processes may involve chemical, physical, or mechanical means. The units being diagnosed and repaired include live matter (e.g. human beings, animals, plants) as well as non-live matter (e.g. buildings, electronic equipment, polymer materials).
-
公开(公告)号:US10369204B2
公开(公告)日:2019-08-06
申请号:US13122007
申请日:2009-10-02
申请人: Jørgen Schøller , Henrik Pedersen , Liselotte Brix
发明人: Jørgen Schøller , Henrik Pedersen , Liselotte Brix
摘要: The present invention relates to methods for construction of pharmamers i.e. vaccine components characterized by their multimerization domain and the attached biologically active molecules, and their use in preparation of vaccines that contains the pharmamers alone or in combination with other molecules. The individual molecules of the construct can be bound to each other or the multimerization domain(s) by covalent or non-covalent bonds, directly or via linkers. The invention further relates to the use of such preparations in vaccine settings aimed to function as preventive/prophylactic or therapeutic vaccines in humans and animals.
-
公开(公告)号:USD792121S1
公开(公告)日:2017-07-18
申请号:US29505790
申请日:2016-02-10
申请人: Henrik Pedersen
设计人: Henrik Pedersen
-
公开(公告)号:US09121110B2
公开(公告)日:2015-09-01
申请号:US10539288
申请日:2003-12-19
IPC分类号: C40B50/00 , C40B20/04 , C40B30/00 , C40B50/10 , C12Q1/68 , C07H21/02 , C40B30/04 , C12N15/10 , C40B40/06 , C40B50/08 , C40B50/04
CPC分类号: C40B30/04 , C12N15/1068 , C40B20/04 , C40B40/06 , C40B50/04 , C40B50/08 , Y10T436/145555
摘要: The present invention is directed to the synthesis of molecules guided by connector polynucleotides (CPNs) capable of hybridizing to complementary connector polynucleotides (CCPNs) harboring at least one functional entity comprising at least one reactive group. At least one of the CCPNs is capable of hybridizing to at least two CPNs. Each CPN will “call” for one or more CCPNs capable of hybridization to the CPN. Following the formation of a supramolecular hybridization complex comprising a plurality of CPNs and a plurality of CCPNs, the reaction of reactive groups results in the formation of a molecule comprising covalently linked functional entities. The formation of the molecule involves the transfer of functional entities from one or more “donor CCPNs” to at least one “acceptor CCPN” with which the transferred functional entities were not associated prior to the transfer.
摘要翻译: 本发明涉及由能够与包含至少一个反应性基团的至少一个功能实体的互补连接多核苷酸(CCPN)杂交的连接体多核苷酸(CPN)引导的分子的合成。 至少有一个CCPN能够与至少两个CPN杂交。 每个CPN将“呼叫”一个或多个能够与CPN杂交的CCPN。 在形成包含多个CPN和多个CCPN的超分子杂交复合物之后,反应性基团的反应导致包含共价连接的功能性实体的分子的形成。 分子的形成涉及将功能性实体从一个或多个“供体CCPN”转移至至少一个转移的功能实体在转移之前与之不相关的“受体CCPN”。
-
公开(公告)号:US20120258126A1
公开(公告)日:2012-10-11
申请号:US13122007
申请日:2009-10-02
申请人: Jørgen Schøller , Henrik Pedersen , Liselotte Brix
发明人: Jørgen Schøller , Henrik Pedersen , Liselotte Brix
CPC分类号: A61K39/00 , A61K38/00 , A61K39/12 , A61K39/21 , A61K47/61 , A61K47/646 , A61K2039/5154 , A61K2039/54 , A61K2039/545 , A61K2039/55505 , A61K2039/55516 , A61K2039/55583 , A61K2039/6087 , A61K2039/625 , C07K14/70539 , C12N2740/16134 , C12N2740/16234 , Y02A50/464
摘要: The present invention relates to methods for construction of pharmamers i.e. vaccine components characterized by their multimerization domain and the attached biologically active molecules, and their use in preparation of vaccines that contains the pharmamers alone or in combination with other molecules. The individual molecules of the construct can be bound to each other or the multimerization domain(s) by covalent or non-covalent bonds, directly or via linkers. The invention further relates to the use of such preparations in vaccine settings aimed to function as preventive/prophylactic or therapeutic vaccines in humans and animals.
摘要翻译: 本发明涉及构建药剂的方法,即以其多聚化结构域和附着的生物活性分子为特征的疫苗组分及其在制备包含单独或与其它分子组合的药剂的疫苗中的用途。 构建体的各个分子可以通过共价或非共价键直接或通过接头彼此结合或多聚化结构域。 本发明还涉及在旨在作为人和动物中的预防/预防或治疗性疫苗的疫苗设置中使用这种制剂。
-
公开(公告)号:US20120083426A1
公开(公告)日:2012-04-05
申请号:US13188031
申请日:2011-07-21
申请人: Claus Lindvald JOHANSEN , Soren Kjaerulff , Susan Mampusta Madrid , Henrik Pedersen , Charlotte Horsmans Poulsen , Masoud Rajabi Zargahi
发明人: Claus Lindvald JOHANSEN , Soren Kjaerulff , Susan Mampusta Madrid , Henrik Pedersen , Charlotte Horsmans Poulsen , Masoud Rajabi Zargahi
IPC分类号: C40B30/08 , G01N33/566 , C12N9/88 , C09K3/00 , G01N33/573 , C07K14/00 , C12Q1/26 , C12Q1/02 , C07K1/14 , C12N9/04
摘要: A method is described for releasing a soluble or membrane associated intracellular protein of interest (POI) comprising the steps of: providing a cell comprising a soluble or membrane associated intracellular POI; contacting the cell with a membrane extracting composition; and causing the POI to be released from the cell under conditions sufficient for the specific release of the POI and in a soluble form.
摘要翻译: 描述了一种用于释放可溶性或膜相关胞内细胞内蛋白质(POI)的方法,包括以下步骤:提供包含可溶性或膜相关细胞内POI的细胞; 使细胞与膜提取组合物接触; 并且使得POI在足以特异性释放POI并且以可溶形式的条件下从细胞释放。
-
公开(公告)号:US20110212090A1
公开(公告)日:2011-09-01
申请号:US13055321
申请日:2009-07-22
申请人: Henrik Pedersen , Liselotte Brix
发明人: Henrik Pedersen , Liselotte Brix
IPC分类号: A61K39/395 , A61P35/00 , A61K31/704 , A61P31/04 , A61P31/06 , A61K31/496 , A61K39/00 , A61K39/02
摘要: A method for the repair of a unit, by specific diagnosis of the undesired state, and its appropriate repair, using said specific diagnosis as a means to repair in an appropriate way said unit. The diagnosis and repair processes may involve chemical, physical, or mechanical means. The units being diagnosed and repaired include live matter (e.g. human beings, animals, plants) as well as non-live matter (e.g. buildings, electronic equipment, polymer materials).
摘要翻译: 通过特定诊断不期望的状态及其适当的修复,使用所述特定诊断作为以适当方式修复所述单元的手段来修复单元的方法。 诊断和修复过程可能涉及化学,物理或机械手段。 被诊断和修复的单位包括活物(例如人类,动物,植物)以及非活体物质(例如建筑物,电子设备,聚合物材料)。
-
公开(公告)号:US07927857B2
公开(公告)日:2011-04-19
申请号:US12034906
申请日:2008-02-21
申请人: Bjarne Ronfeldt Nielsen , Allan Svendsen , Henrik Pedersen , Jesper Vind , Hanne Vang Hendriksen , Torben Peter Frandsen
发明人: Bjarne Ronfeldt Nielsen , Allan Svendsen , Henrik Pedersen , Jesper Vind , Hanne Vang Hendriksen , Torben Peter Frandsen
CPC分类号: C12N9/2428 , C12P19/20 , Y02E50/17
摘要: The invention relates to a variant of a parent fungal glucoamylase, which exhibits altered properties, in particular improved thermal stability and/or increased specific activity.
摘要翻译: 本发明涉及亲本真菌葡糖淀粉酶的变体,其具有改变的性质,特别是改进的热稳定性和/或增加的比活性。
-
公开(公告)号:US07919275B2
公开(公告)日:2011-04-05
申请号:US12719648
申请日:2010-03-08
CPC分类号: C12Q1/6895 , C12N9/14
摘要: An isolated mutant host cell produced by disrupting or deleting, in a parent cell, a nucleic acid sequence encoding an oxaloacetate hydrolase, or a promoter thereof, which results in the mutant cell producing less of the oxaloacetate hydrolase than the parent cell is disclosed. The disclosure also relates to recombinant methods for producing the products such as polypeptides.
摘要翻译: 公开了一种分离的突变宿主细胞,其通过在母体细胞中破坏或缺失编码草酰乙酸水解酶的核酸序列或其启动子,导致突变体细胞产生比母细胞少的草酰乙酸酯水解酶。 本公开还涉及用于生产诸如多肽的产物的重组方法。
-
-
-
-
-
-
-
-
-